EBV-positive mucocutaneous ulcer in organ transplant recipients: A localized indolent posttransplant lymphoproliferative disorder

Keyphrases

• Post-transplant Lymphoproliferative Disorder 100%
• Epstein-Barr Virus 100%
• Organ Transplant Recipients 100%
• Epstein-Barr Virus-positive mucocutaneous Ulcer 100%
• Immunosuppression 20%
• Plasma Epstein-Barr Virus DNA 20%
• Large Cell 20%
• In(III) 20%
• Lung 10%
• Transplant Recipients 10%
• Transplant Patients 10%
• Rituximab 10%
• Ulcer 10%
• Renal Transplant 10%
• Gastrointestinal Tract 10%
• Oral mucosa 10%
• Immunocompromised Patients 10%
• B-cell Lymphoproliferative Disorder 10%
• CD30 10%
• Inflammatory Cells 10%
• Solid Organ Transplant Recipients 10%
• Immunosuppressive Therapy 10%
• Conservative Management 10%
• Epstein-Barr Virus-encoded RNA 10%
• Lymphoproliferation 10%
• CD20 10%
• Reed-Sternberg Cells 10%
• Large B-cell 10%
• Working Diagnosis 10%

Medicine and Dentistry

• Posttransplant Lymphoproliferative Disease 100%
• Epstein Barr Virus 100%
• Ulcer 100%
• Immunosuppressive Treatment 20%
• B Cell 13%
• Virus DNA 13%
• Large Cell 13%
• Lung 6%
• Kidney Graft 6%
• Conservative Treatment 6%
• Awareness 6%
• Rituximab 6%
• Oral Mucosa 6%
• CD20 6%
• Lymphocyte Proliferation 6%
• Immunocompromised Patient 6%
• Inflammatory Cell 6%
• Lymphoproliferative Disease 6%
• Gastrointestinal Tract 6%

Immunology and Microbiology

• Lymphoproliferative Disorders 100%
• Epstein Barr Virus 100%
• Immunosuppression 13%
• B Cell 13%
• DNA Virus 13%
• Immunosuppressive Therapy 6%
• Gastrointestinal Tract 6%
• Rituximab 6%
• Awareness 6%
• CD20 6%
• Lymphocyte Proliferation 6%
• Mouth Mucosa 6%
• Immunocompromised Patient 6%
• Inflammatory Cell 6%